Results 11 to 20 of about 22,509 (201)
Case Report: Familial partial lipodystrophy, description of novel and ultrarare variants with distinct phenotypic spectrum [PDF]
Frontiers in EndocrinologyFamilial partial lipodystrophy (FPLD) is a rare inherited disorder characterized by selective loss of subcutaneous fat and severe metabolic complications.
Silvia Magno +14 more
doaj +2 more sources
Frontiers in Endocrinology, 2022 Growth hormone (GH) and insulin-like growth factor 1 (IGF-1) are essential to normal growth, metabolism, and body composition, but in acromegaly, excesses of these hormones strikingly alter them.
Pamela U. Freda
doaj +3 more sources
Dermatologic Clinics, 2008 Lipodystrophy syndromes comprise a group of rare, heterogeneous disorders characterized by progressive loss of fat tissue, mainly from subcutaneous compartment and occasionally affecting visceral fat. Lipoatrophy may be partial, localized, or generalized.
Pedro Herranz +2 more
exaly +4 more sources
Endocrinology and Metabolism Clinics of North America, 2016 Lipodystrophies are heterogeneous disorders characterized by varying degrees of body fat loss and predisposition to insulin resistance and its metabolic complications. They are subclassified depending on degree of fat loss and whether the disorder is genetic or acquired. The two most common genetic varieties include congenital generalized lipodystrophy
Abhimanyu Garg, Iram Hussain
exaly +4 more sources
Pathways to improving the awareness, diagnosis and management of lipodystrophy in Brazil: an expert panel discussion [PDF]
Diabetology & Metabolic SyndromeBackground Lipodystrophy syndromes are a group of rare, clinically complex disorders characterized by a partial or generalized lack of adipose tissue. Affected individuals develop severe metabolic comorbidities and frequently display absolute or relative
Josivan Gomes Lima +7 more
doaj +2 more sources
Journal of Education, Health and Sport, 2018 Korabiusz Katarzyna, Wawryków Agata. Causes of lipodystrophy. Journal of Education, Health and Sport. 2018;8(9):1765-1770. eISNN 2391-8306. DOI http://dx.doi.org/10.5281/zenodo.1410147 http://ojs.ukw.edu.pl/index.php/johs/article/view/5921 https://pbn.nauka.gov.pl/sedno-webapp/works/876219 The journal has had 7 points in Ministry of ...
Katarzyna Korabiusz, Agata Wawryków
openaire +6 more sources
European lipodystrophy registry: background and structure [PDF]
Orphanet Journal of Rare Diseases, 2020 Background Lipodystrophy syndromes comprise a group of extremely rare and heterogeneous diseases characterized by a selective loss of adipose tissue in the absence of nutritional deprivation or catabolic state. Because of the rarity of each lipodystrophy
Julia von Schnurbein +24 more
doaj +2 more sources
Lipodystrophy : focus on HIV Lipodystrophy [PDF]
, 2017 Lipodystrophy is a rare condition which can be inherited or acquired, localised or generalised. It is characterised by abnormal adipose tissue distribution and in some cases underlying metabolic derangement, including diabetes mellitus, hypertriglyceridemia, hepatic steatosis, polycystic ovaries and acanthosis nigricans.
Giordano Imbroll, Miriam +2 more
core +4 more sources
Recent developments in lipodystrophy
Current Opinion in Lipidology, 2019 Purpose of review Lipodystrophy syndromes have an estimated prevalence of 1.3–4.7 cases per million and as with other rare diseases conducting research can be challenging. The present review highlights recently published work that has provided insights into the field of non-HIV--associated lipodystrophy syndromes.
Melvin, Audrey +2 more
openaire +6 more sources
Biological Depiction of Lipodystrophy and Its Associated Challenges Among HIV AIDS Patients: Literature Review [PDF]
HIV/AIDS: Research and Palliative CareTolera Ambisa Lamesa School of Medical Laboratory Science, Jimma University, Jimma, EthiopiaCorrespondence: Tolera Ambisa Lamesa, Email toleraambisa@gmail.comAbstract: Lipodystrophy syndrome is a medical condition characterized by the absence of adipose ...
Lamesa TA
doaj +1 more source